HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia.

AuthorsPeter F Buckley, Brian J Miller, Anilkumar Pillai, Brian Kirkpatrick
JournalSchizophrenia research (Schizophr Res) Vol. 158 Issue 1-3 Pg. 268-9 (Sep 2014) ISSN: 1573-2509 [Electronic] Netherlands
PMID25052781 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antipsychotic Agents
  • Cysteamine
Topics
  • Adult
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Cysteamine (adverse effects, therapeutic use)
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Male
  • Psychiatric Status Rating Scales
  • Schizophrenia (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: